Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) (/* 2014 Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI or valve interventions: a joint consensus document of EHRA, EAPCI, ACCA endorsed by HRS and APHRS (DO NOT EDIT){{cite journal| author=Task Force Membe...) |
||
Line 10: | Line 10: | ||
==Overview== | ==Overview== | ||
==2014 Management of | ==2014 Management of Antithrombotic Therapy in AF Patients Presenting with ACS and/or Undergoing PCI or Valve Interventions: A Joint Consensus Document of EHRA, EAPCI, ACCA Endorsed by HRS and APHRS (DO NOT EDIT)<ref name="pmid25154388">{{cite journal| author=Task Force Members. Lip GY, Windecker S, Huber K, Kirchhof P, Marin F et al.| title=Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). | journal=Eur Heart J | year= 2014 | volume= | issue= | pages= | pmid=25154388 | doi=10.1093/eurheartj/ehu298 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25154388 }} </ref> == | ||
==References== | ==References== |
Revision as of 17:53, 4 September 2014
Resident Survival Guide |
Atrial Fibrillation Microchapters | |
Special Groups | |
---|---|
Diagnosis | |
Treatment | |
Cardioversion | |
Anticoagulation | |
Surgery | |
Case Studies | |
Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention On the Web | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
2014 Management of Antithrombotic Therapy in AF Patients Presenting with ACS and/or Undergoing PCI or Valve Interventions: A Joint Consensus Document of EHRA, EAPCI, ACCA Endorsed by HRS and APHRS (DO NOT EDIT)[1]
References
- ↑ Task Force Members. Lip GY, Windecker S, Huber K, Kirchhof P, Marin F; et al. (2014). "Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)". Eur Heart J. doi:10.1093/eurheartj/ehu298. PMID 25154388.